Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Aethlon Medical (AEMD) Return on Sales (2016 - 2023)

Aethlon Medical (AEMD) has disclosed Return on Sales for 13 consecutive years, with 21.33% as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Return on Sales rose 98572.0% year-over-year to 21.33%, compared with a TTM value of 21.33% through Dec 2023, up 98572.0%, and an annual FY2025 reading of 2.94%, changed N/A over the prior year.
  • Return on Sales was 21.33% for Q4 2023 at Aethlon Medical, down from 20.26% in the prior quarter.
  • Across five years, Return on Sales topped out at 2.12% in Q4 2019 and bottomed at 1007.05% in Q4 2022.
  • Average Return on Sales over 5 years is 113.75%, with a median of 20.95% recorded in 2023.
  • The sharpest move saw Return on Sales tumbled -85937bps in 2022, then skyrocketed 98572bps in 2023.
  • Year by year, Return on Sales stood at 2.12% in 2019, then tumbled by -85bps to 3.91% in 2020, then crashed by -3674bps to 147.69% in 2021, then plummeted by -582bps to 1007.05% in 2022, then skyrocketed by 98bps to 21.33% in 2023.
  • Business Quant data shows Return on Sales for AEMD at 21.33% in Q4 2023, 20.26% in Q3 2023, and 21.36% in Q2 2023.